The civic record
Read. Follow. Verify.Maryland Creates Grant Program to Fund Advanced Manufacturing and Regenerative Medicine
Last action · May 12, 2026: Approved by the Governor - Chapter 379Sponsors: Craig Zucker and 2 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
Maryland established the Maryland Advanced Manufacturing Grant Program to provide grants for companies specializing in and advanced manufacturing, taking effect July 1, 2026.
Advanced manufacturing companies can receive state grant funds for facility construction, infrastructure improvements, and equipment purchases.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Companies that specialize in regenerative medicine and other advanced manufacturing
Eligible companies may apply for grants to fund space acquisition, infrastructure improvements, and equipment.
Maryland Technology Development Corporation
The Corporation is tasked with administering the program, the fund, and establishing eligibility and evaluation criteria.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What can grant recipients use the money for?
Who administers the new grant program and its fund?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Current status: Signed into law.
Procedural history
15 actions- May 12, 2026Governor of MarylandEnrolledApproved by the Governor - Chapter 379
- Apr 13, 2026SenateFloorReturned Passed
- Apr 13, 2026HouseFloorThird Reading Passed (124-12)
- Apr 9, 2026HouseFloorFavorable Adopted Second Reading Passed
- Apr 9, 2026HouseCommitteeFavorable Report by Economic Matters
- Mar 24, 2026HouseHearing 4/01 at 1:00 p.m.
Show 9 earlier actions
- Mar 24, 2026HouseHearing canceled
- Mar 21, 2026HouseHearing 4/02 at 1:00 p.m.
- Mar 20, 2026HouseCommitteeReferred Economic Matters
- Mar 19, 2026SenateFloorThird Reading Passed (45-0)
- Mar 18, 2026SenateFloorSecond Reading Passed with Amendments
- Mar 18, 2026SenateFavorable with Amendments { 583425/1 Adopted
- Mar 18, 2026SenateCommitteeFavorable with Amendments Report by Finance
- Feb 12, 2026SenateHearing 3/05 at 1:00 p.m.
- Feb 6, 2026SenateIntroducedFirst Reading Finance
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Connected Entities
Sources
mgaleg.maryland.gov
Analysis Score
0–100- Significance65How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools